SCHEMBL31468636

SCHEMBL31468636

C=Cc1ccccc1[Si](C)(C)CCCN(C)C

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HRH1 P35367 4/20 0.34
HTR2A P28223 2/20 0.34
SIGMAR1 Q99720 2/20 0.34
KMT2A Q03164 2/20 0.34
NPC1 O15118 1/20 0.34
POLB P06746 1/20 0.34
SLC2A1 P11166 1/20 0.34
APOBEC3A P31941 1/20 0.34
RAD52 P43351 1/20 0.34
RAB9A P51151 1/20 0.34
APOBEC3G Q9HC16 1/20 0.34
LMNA P02545 2/20 0.32
ALDH1A1 P00352 5/20 0.32
KCNH2 Q12809 2/20 0.31
HTR2B P41595 2/20 0.31
SLC22A1 O15245 1/20 0.31
CHRM2 P08172 1/20 0.31
CHRM4 P08173 1/20 0.31
HTR1A P08908 1/20 0.31
CHRM5 P08912 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31468579 0.85 SIGMAR1 (0.37) HRH1HTR2ASIGMAR1ALDH1A1KCNH2
SCHEMBL31468453 0.84 HTT (0.35) KMT2AKCNH2DRD2DRD3OPRK1
SCHEMBL31468473 0.83 ALDH1A1 (0.35) ALDH1A1KDM4E
SCHEMBL7064746 0.82 ALDH1A1 (0.34) ALDH1A1
SCHEMBL31468576 0.81 KDM4E (0.34) HRH1HTR2ASIGMAR1LMNAALDH1A1
SCHEMBL8522100 0.79 KCNH2 (0.36) KMT2ALMNAALDH1A1KCNH2MEN1
SCHEMBL31468618 0.79 KDM4E (0.33) HRH1HTR2ASIGMAR1ALDH1A1LSS
SCHEMBL27258709 0.77 ALDH1A1 (0.35) ALDH1A1
Hydrochloric Acid SCHEMBL27258912 0.76 ALDH1A1 (0.34) ALDH1A1
SCHEMBL18135557 0.75 ALDH1A1 (0.32) ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4541800-A1 NITROGEN-CONTAINING SILANE COMPOUND AND METHOD FOR PRODUCING SAME Shin-Etsu Chemical Co., Ltd. (JP) 2025-04-23 EP disclosed
US-20250122230-A1 NITROGEN-CONTAINING SILANE COMPOUND AND METHOD FOR PRODUCING SAME SHIN-ETSU CHEMICAL CO., LTD. (JP) 2025-04-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250122230-A1 NITROGEN-CONTAINING SILANE COMPOUND AND METHOD FOR PRODUCING SAME HRH3, HRH4, OR10J3 HRH1 4/4885HTR2A 1735/4885SIGMAR1 176/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.